Welcome

Restricted Export of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients Allowed

The DGFT vide Notification No. 08/2015-2020, dated June 14, 2021, amended Notification No. 01/2015-2020, dated April 11, 2021, as under:

No ITC HS Codes Description Present Policy Revised Policy
207AA Ex 293499

Ex 300490

Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (“API”) Prohibited Restricted

 

Earlier export of Injection Remdesivir and Remdesivir API was not permitted but now with the above amendment they can be exported against Advance Authorization. Further, export of Injection Remdesivir and Remdesivir API against Advance Authorizations issued under Chapter 4 of Foreign Trade Policy/Handbook of Procedures shall not require separate export authorisation or permission

Leave a Reply

Your email address will not be published. Required fields are marked *